Aclaris Therapeutics, Inc. (ACRS) Revenue Growth
Aclaris Therapeutics, Inc. (ACRS) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-12-31 | N/A |
| 2018-12-31 | 265.48% |
| 2019-12-31 | -31.28% |
| 2020-12-31 | 53.35% |
| 2021-12-31 | 4.30% |
| 2022-12-31 | 340.05% |
| 2023-12-31 | 5.03% |
| 2024-12-31 | -40.09% |
| 2025-12-31 | -58.19% |
How ACRS compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| ICUI | ICU Medical Inc. | -6.33% |
| DYAI | Dyadic International Inc. | -11.59% |
| OCUL | Ocular Therapeutix Inc. | -18.47% |
| OSUR | OraSure Technologies Inc. | -38.10% |
| NKTR | Nektar Therapeutics | -43.89% |
These are five companies in the same sector as ACRS with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Aclaris Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("ACRS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ACRS | $6.18 | +2.66% | 1.55M |
| 3 | ||||
| 4 | ||||
| 5 |